Aurinia Pharmaceuticals Inc. (AUPH) short interest & options flow
NASDAQAUPH short interest has just hit its lowest level in over a year, yet options traders are suddenly the most defensive they have been in months, a divergence that frames the whole setup heading into a November 5 earnings date. Short interest in Aurinia Pharmaceuticals has fallen to 5.9% of the free float, down 12% over the past month and down roughly a third from where it stood in…
AUPH put/call ratio hits 0.88—4.1 standard deviations above the 20-day mean of 0.33—signaling extreme bullish options positioning as shares rally 1.8% in a single session.
- Market cap
- $2.22B
- Next earnings
- 5 Nov 2026
Key data as of 4 Nov 2026
AUPH news and analysis
RSSNo long-form analysis yet for AUPH. Pulse alerts and the live data picture are available on ORTEX.
Open AUPH on ORTEX →Want the live picture for AUPH?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AUPH — free to start on ORTEX.
Sign up for free →Open AUPH on ORTEX